Display options
Cite
Adland E, Klenerman P, Goulder P, et al. Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era. Front Microbiol. 2015;6:1016doi: 10.3389/fmicb.2015.01016.
Adland, E., Klenerman, P., Goulder, P., & Matthews, P. C. (2015). Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era. Frontiers in microbiology, 61016. https://doi.org/10.3389/fmicb.2015.01016
Adland, Emily, et al. "Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era." Frontiers in microbiology vol. 6 (2015): 1016. doi: https://doi.org/10.3389/fmicb.2015.01016
Adland E, Klenerman P, Goulder P, Matthews PC. Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era. Front Microbiol. 2015 Sep 24;6:1016. doi: 10.3389/fmicb.2015.01016. eCollection 2015. PMID: 26441939; PMCID: PMC4585099.
Copy Download .nbib Format: NLM
Share it on

Front Microbiol. 2015 Sep 24;6:1016. doi: 10.3389/fmicb.2015.01016. eCollection 2015.

Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era.

Frontiers in microbiology

Emily Adland, Paul Klenerman, Philip Goulder, Philippa C Matthews

Affiliations

  1. Department of Paediatrics, Peter Medawar Building for Pathogen Research, University of Oxford Oxford, UK.
  2. Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford Oxford, UK ; Department of Infectious Diseases and Microbiology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust Oxford, UK ; National Institute for Health Research Biomedical Research Centre Oxford, UK.
  3. Department of Paediatrics, Peter Medawar Building for Pathogen Research, University of Oxford Oxford, UK ; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal Durban, South Africa.
  4. Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford Oxford, UK ; Department of Infectious Diseases and Microbiology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust Oxford, UK.

PMID: 26441939 PMCID: PMC4585099 DOI: 10.3389/fmicb.2015.01016

Abstract

Human Cytomegalovirus (CMV) is a well-recognized pathogen in the context of HIV infection, but since the roll out of ART, clinical and scientific interest in the problem of HIV/CMV coinfection has diminished. However, CMV remains a significant cofactor in HIV disease, with an influence on HIV acquisition, disease progression, morbidity, and mortality. Disease manifestations may be a result of direct interplay between the two viruses, or may arise as a secondary consequence of immune dysregulation and systemic inflammation. The problem is most relevant when the rates of coinfection are high, most notably in sub-Saharan Africa, and in children at risk of acquiring both infections early in life. Understanding the interplay between these viruses and developing strategies to diagnose, treat and prevent CMV should be a priority.

Keywords: CMV; HIV-1; antiretroviral therapy; coinfection; immune activation; pediatric infectious diseases; sub-Saharan Africa

References

  1. J Clin Invest. 1992 Feb;89(2):574-80 - PubMed
  2. J Infect Dis. 2015 Jan 15;211(2):169-71 - PubMed
  3. PLoS One. 2014 Dec 18;9(12):e114870 - PubMed
  4. PLoS One. 2007 Jun 06;2(6):e492 - PubMed
  5. N Engl J Med. 1999 Jul 8;341(2):77-84 - PubMed
  6. Blood. 1997 Feb 15;89(4):1357-63 - PubMed
  7. PLoS One. 2014 Apr 03;9(4):e93702 - PubMed
  8. Niger Postgrad Med J. 2009 Jun;16(2):139-42 - PubMed
  9. Enferm Infecc Microbiol Clin. 2004 Mar;22(3):142-9 - PubMed
  10. PLoS One. 2014 Feb 04;9(2):e87855 - PubMed
  11. J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):538-44 - PubMed
  12. Lancet. 2004 Jun 26;363(9427):2116-21 - PubMed
  13. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8642-6 - PubMed
  14. J Immunol. 1989 Jul 15;143(2):470-5 - PubMed
  15. AIDS Res Hum Retroviruses. 2015 Sep;31(9):905-12 - PubMed
  16. Clin Microbiol Infect. 2015 May;21(5):511.e1-7 - PubMed
  17. J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):486-91 - PubMed
  18. BMC Infect Dis. 2008 Oct 15;8:139 - PubMed
  19. J Med Virol. 2009 Nov;81(11):1860-8 - PubMed
  20. Cell Death Dis. 2010 Nov 11;1:e99 - PubMed
  21. J Virol. 2007 Jun;81(11):5766-76 - PubMed
  22. AIDS. 2015 Jan 14;29(2):145-53 - PubMed
  23. Arch Virol. 1995;140(5):927-35 - PubMed
  24. Nature. 1990 Feb 15;343(6259):659-61 - PubMed
  25. Science. 1997 Jun 20;276(5320):1874-8 - PubMed
  26. Clin Infect Dis. 2014 May;58(10):1467-72 - PubMed
  27. J Infect Dis. 2008 Mar 1;197(5):658-62 - PubMed
  28. N Engl J Med. 2009 Mar 19;360(12):1191-9 - PubMed
  29. Haematologica. 2015 Jan;100(1):114-23 - PubMed
  30. J Infect Dis. 1989 May;159(5):860-5 - PubMed
  31. Lancet. 1989 Sep 16;2(8664):681 - PubMed
  32. PLoS One. 2014 Jun 10;9(6):e99243 - PubMed
  33. J Clin Virol. 2013 Sep;58(1):74-8 - PubMed
  34. PLoS One. 2008 Aug 06;3(8):e2905 - PubMed
  35. Curr HIV Res. 2013 Jan;11(1):10-23 - PubMed
  36. Pediatr Res. 2001 Jan;49(1):101-10 - PubMed
  37. Clin Infect Dis. 2015 Feb 1;60(3):423-31 - PubMed
  38. Clin Infect Dis. 2003 Apr 1;36(7):922-4 - PubMed
  39. J Clin Virol. 2007 Nov;40(3):180-5 - PubMed
  40. Clin Infect Dis. 2014 Mar;58(5):728-35 - PubMed
  41. Int J Infect Dis. 2012 Dec;16(12):e879-85 - PubMed
  42. Curr Opin Virol. 2014 Jun;6:13-23 - PubMed
  43. Clin Microbiol Rev. 2013 Jan;26(1):86-102 - PubMed
  44. Lancet. 2011 Apr 9;377(9773):1256-63 - PubMed
  45. Isr Med Assoc J. 2005 Apr;7(4):237-40 - PubMed
  46. Int J Infect Dis. 2014 May;22:44-8 - PubMed
  47. J Investig Dermatol Symp Proc. 2001 Dec;6(3):212-8 - PubMed
  48. J Clin Virol. 2006 Apr;35(4):489-92 - PubMed
  49. PLoS One. 2011;6(10):e25571 - PubMed
  50. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2336-40 - PubMed
  51. Transpl Infect Dis. 2015 Apr;17 (2):163-73 - PubMed
  52. Immunology. 2008 Jul;124(3):388-400 - PubMed
  53. Clin Exp Immunol. 1998 Jan;111(1):3-11 - PubMed
  54. J Immunol. 2015 Sep 1;195(5):2273-81 - PubMed
  55. J Int Assoc Physicians AIDS Care (Chic). 2010 Mar-Apr;9(2):94-7 - PubMed
  56. Pediatr Infect Dis J. 2008 Sep;27(9):841-3 - PubMed
  57. J Virol. 2012 Oct;86(20):11373-9 - PubMed
  58. J Infect Dis. 1995 Jan;171(1):26-32 - PubMed
  59. Clin Infect Dis. 2003 Aug 15;37(4):567-78 - PubMed
  60. J Infect Dis. 2015 Jan 15;211(2):187-96 - PubMed
  61. Pediatr Pulmonol. 2010 Jul;45(7):650-5 - PubMed
  62. J Clin Microbiol. 2005 Sep;43(9):4713-8 - PubMed
  63. Rev Med Virol. 2010 Jul;20(4):202-13 - PubMed
  64. AIDS. 2009 Jan 2;23(1):117-24 - PubMed
  65. J Infect Dis. 2015 Jan 15;211(2):178-86 - PubMed
  66. Clin Infect Dis. 2004 Jul 15;39(2):233-9 - PubMed
  67. Clin Microbiol Rev. 2009 Jan;22(1):76-98, Table of Contents - PubMed
  68. Int J Environ Res Public Health. 2015 Jul 07;12(7):7585-92 - PubMed

Publication Types

Grant support